跳至主要内容
临床试验/NCT03793309
NCT03793309已完成1 期

A Randomized Controlled Trial on the Effect of 400 vs. 800 IU of Vitamin D on T Regulatory Cells in Preterm Infants

Cairo University0 个研究点目标入组 40 人开始时间: 2017年1月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
40
主要终点
Percent Change in The Number of T Regulatory Cells

研究概览

简要总结

This study evaluate the effect of two different doses of vitamin D on T-regulatory cells in preterm infants. Half of the subjects receives 400 IU vitamin D and the other half receives 800 IU vitamin D.

详细描述

Vitamin D, in addition to its bone mineralization effect, is an immune- modulatory agent. Fetal and premature cellular immunity are generally delayed. Whether vitamin D can enhance cellular immunity by increasing T regulatory cells is unknown. The effect of two different doses of vitamin D; 400 IU and 800 IU will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm infants with gestational age 28-33 weeks

排除标准

  • Necrotizing enterocolitis
  • Bowel perforation
  • Chromosomal anomalies
  • Inborn errors of metabolism
  • Major congenital anomalies

研究组 & 干预措施

Low dose

Experimental

Subjects in this group receive 400 IU vitamin D daily for 4 weeks.

干预措施: Vitamin D (Drug)

High dose

Experimental

Subjects in this group receive 800 IU vitamin D daily for 4 weeks.

干预措施: Vitamin D (Drug)

结局指标

主要结局

Percent Change in The Number of T Regulatory Cells

时间窗: At 4 weeks (compared to baseline)

Flow cytometry assessment of CD4+ , CD25+ with expression of FOXP3 will be used to identify T Regulatory cells

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lamiaa Mohsen

professor of Pediatrics

Cairo University

相似试验